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Summary. Macular corneal dystrophy is a rare
autosomal recessive eye disease affecting primarily the
corneal stroma. Abnormal accumulation of proteoglycan
aggregates has been observed intra- and extracellularly
in the stromal layer. In addition to the stromal
keratocytes and corneal lamellae, deposits are also
present in the basal epithelial cells, endothelial cells and
Descemet's membrane. Misfolding of proteins has a
tendency to gather into aggregating deposits. We studied
interaction of molecular chaperones and proteasomal
clearance in macular dystrophy human samples and in
human corneal HCE-2 epithelial cells. Seven cases of
macular corneal dystrophy and four normal corneal
buttons collected during corneal transplantation were
examined for their expression patterns of heat shock
protein 70, ubiquitin protein conjugates and
SQSTM1/p62. In response to proteasome inhibition the
same proteins were analyzed by western blotting. Slit-
lamp examination, in vivo confocal cornea microscopy
and transmission electron microscopy were used for
morphological analyses. Heat shock protein 70, ubiquitin
protein conjugates and SQSTM1/p62 were upregulated
in both the basal corneal epithelial cells and the stromal
keratocytes in macular corneal dystrophy samples that
coincided with an increased expression of the same
molecules under proteasome inhibition in the HCE-2
cells in vitro. We propose a novel regulatory mechanism
that connects the molecular chaperone and proteasomal
clearance system in the pathogenesis of macular corneal
dystrophy.
Key words: Heat shock proteins, Macular corneal
dystrophy, Misfolding, Protein aggregation, Ubiquitin/
proteasome pathway
Introduction
Macular corneal dystrophy (Groenouw corneal
dystrophy type II, MIM #217800) is an uncommon,
autosomal recessive disorder affecting the corneal
stroma (Weiss et al., 2008). Most cases are linked to
mutations in the carbohydrate sulfotransferase gene
(CHST6) on chromosome 16q22 (Akama et al., 2000).
Macular corneal dystrophy (MCD) has been classified as
immunophenotype I, IA and II based on sulfated keratan
sulfate level of the serum and cornea (Klintworth et al.,
1986, 1997). It is characterized by abnormal
accumulation of proteoglycan aggregates intra- and
extracellularly in the stromal layer resulting in various
irregular gray-white opacities extending to the peripheral
and posterior stroma (Klintworth and Smith, 1977;
Jonasson et al., 1989; Klintworth, 2009). In addition to
the keratocytes and corneal lamellae, deposits are also
present in the basal epithelial cells, endothelial cells and
Descemet's membrane, and recurrent epithelial erosions
are seen. As the disease progresses, the aggregates
become more confluent with diffuse corneal haze.
Macular corneal dystrophy is accompanied by decreased
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corneal thickness. This condition may lead to severe
bilateral visual impairment until the fourth-fifth decade
of life (Klintworth, 2009). 
Misfolded proteins have a tendency to gather into
detrimental aggregates (Tyedmers et al., 2010). In
addition to stress-damaged proteins, the nonfunctional
proteins may also be a result of gene mutations and
disturbances in protein synthesis leading to misfolding
and aggregation (Goldberg, 2003). Prior to the ultimate
aggregation cellular defense mechanism is triggered,
called the molecular chaperone response (Heat shock
protein response; Hsp response), which attempts to
restore proteins to their original folding state, retain their
function and reduce the aggregation process (Kästle and
Grune, 2012). If this response is unsuccessful, misfolded
soluble proteins are tagged with a small polypeptide
ubiquitin (Ub) that directs the complex to the
ubiquitin/proteasomal protein degradation pathway
(UPP) (Jung et al., 2009). The eukaryotic proteasome is
a multicatalytic proteolytic complex present in cytosol,
nucleus and microsomes (Kopito, 2000). The
proteasome recognizes and selectively degrades
ubiquitinated proteins. The UPP is one of the most
important cellular systems to remove misfolded proteins.
Accumulation of ubiquinated proteins is a hallmark of
impaired clearance via proteasomes that may lead to
protein aggregation intra- and extracellularly (Carrard et
al., 2002). The ability of SQSTM1/p62 to bind non-
covalently to ubiquitin was first described by Vadlamudi
et al. (1996), but only later was it realized that
SQSTM1/p62 is one of the main molecules controlling
the shuttling of ubiquitinated substrates towards
proteasomal degradation (Janse et al., 2004; Seibenhener
et al., 2004; Babu et al., 2005).
Since MCD is clearly associated to the aggregation
process, our aim was to study the role of proteasomal
clearance in the MCD pathology. Here we show for the
first time that Hsp70, Ub protein conjugates and
SQSTM1/p62 and protein aggregates are highly
upregulated in both corneal basal epithelium and stroma
cells of MCD samples and in response to proteasomal
inhibition in corneal HCE-2 epithelial cells. Thus, we
strongly believe that impaired UPP clearance is an
important regulatory mechanism factor in the
pathogenesis of MCD and may open novel ways to
understand crosstalk of corneal epithelium and stroma.
Materials and methods
Tissue samples
Tissue samples were obtained from 7 patients who
underwent penetrating keratoplasty. Donor cornea not
used for corneal transplantation were obtained from the
Cornea Bank Debrecen (Department of Ophthalmology,
University of Debrecen /UD/, Medical and Health
Science Centre /MHSC/) served as normal control
corneas. MCD samples were obtained from the
Department of Ophthalmology, UD MHSC and the Eye
Tissue Bank in Katowice (Ophthalmology Clinic, the
Central Railway Hospital, Medical University of Silesia
in Katowice). The analysis was performed on 50
sections derived from 11 corneas (7 MCD corneas of 7
patients with a mean age of 45±17 years; 5 males, 2
females and 4 control corneas of 2 patients with a mean
age of 51±8 years; 1 male, 1 female). The MCD
diagnosis was based on clinical signs and the family
history questionnaire.
In vivo corneal confocal microscopy
Patients scheduled for corneal transplantation (from
which tissue samples for further analysis were obtained)
underwent in vivo corneal confocal microscopy (Rostock
Cornea Module, Heidelberg Engineering Retina
Tomograph III, Dossenheim, Germany). After topical
anesthesia (Proxymetacaine hydrochloride, Alcon) scans
of full thickness dystrophic corneas (from tear film to
endothelium) were made. For this examination we used
2 different scanning frames - 300x300 μm and 400x400
μm. Scans were made with 1 μm step with continuous
recording. For comparison, healthy corneas from 2
persons were examined.
Laboratory procedures
For histology and immunohistochemistry, corneal
buttons were fixed in Saint-Marie solution (Saint-Marie,
1962; Felszeghy et al., 2004), dehydrated, and embedded
in paraffin. Sections from 5 μm to 7 μm thickness were
cut. All aspects of experimental procedures and
protocols were approved by the Board of Scientific
Committee of University of Debrecen and Katowice.
Participants provided their written informed consent for
the human material in this study.
Histochemistry
Alcian blue staining was carried out according to
standard protocols and observed under a light
microscope Nikon Eclipse 800 microscope equipped
with 60x PanFlour Nikon objective (Nikon Corporation
Instruments Company, Japan).
Immunohistochemistry
For multiple labeling combinations of 3 primary
antibodies were applied as a cocktail diluted in blocking
solution, as described below. In humidity chambers a
mixture of antibodies were placed into sections, which
contained anti-hsp70 (diluted 1:100 /ENZO,
Farmingdale, NY, USA/), anti Ubiquitin (diluted 1:200
/DAKO, Golstrup, Denmark/) and SQSTM1/p62
(diluted 1:100 /Progen, Heidelberg, Germany/). After 3
days incubation at 4°C the slides were rinsed in PBS and
the mixture of secondary antibodies (Alexa Fluor 488
anti-mouse, Alexa Fluor 647 anti-guinea pig /Invitrogen,
Camarillo, CA, USA/ and Alexa 546 anti rabbit
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/Molecular Probes, Garnd Island, NY, USA) was added
for 2 hours at room temperature in 1/200 dilution. The
slides were washed in PBS and the nuclei were stained
using DAPI (4,6- diamidino-2-fenilindole, dihydro-
cloride; 1:1000 /Molecular Probes, Camarillo, CA,
USA/) in PBS containing 0.1% saponin for 30 min and
covered with Vectashield mounting Media (Vector
Laboratories, Burlingame, CA, USA). As negative
controls for each double label, the same procedure as
above was followed except that one of the primary
antibodies was omitted. 
Confocal microscopy 
Image acquisition was performed on an Olympus
FV1000 confocal laser scanning system built on an IX81
inverted microscope equipped with an ultraviolet laser
diode (405 nm), a multiline Ar laser (458, 488 and 514
nm), an HeNe(G) laser (543 nm) and an HeNe(R) laser
(633 nm) (Olympus, Tokyo, Japan). Single 1 μm thick
optical sections were acquired using a 60x oil immersion
objective (NA:1.42, Plan Apochromat).
DAPI was excited by a 405 nm laser diode and
fluorescence was detected between 425-475 nm. Alexa
488 was excited at 488 nm and fluorescence was
detected in the 500-550 nm spectral region. Alexa 546
was excited at 543 nm and fluorescence was collected in
the 555-655 nm spectral range. Alexa 647 was excited at
633 nm, and the emission was detected through 640 nm
long-pass filter.
The confocal settings (laser power, gain, offset,
confocal aperture, pixel size) were identical for all scans
and kept constant during imaging. Digital images were
captured with Fluoview ASW 3.1 software and
processed with Adobe Photoshop CS6 software. In all
imaging processes, gamma adjustment was done in the
whole image to maintain appropriate contrast.
Cell culture and treatments
Cells used in this study were cultured as recently
documented (Kinnunen et al., 2013). Fresh medium was
supplied to the cells every other day and the cells were
subcultured twice a week using 0.25% trypsin-EDTA
(cat. no. 25200056; Life Technologies, Invitrogen,
Camarillo, CA, USA) to detach the cells from plates. In
proteasome experiments, the cells were exposed to 1 µM
MG-132 proteasome inhibitor (Calbiochem, 474790) for
24 hours (h).
Western blotting
For western blotting, whole cell extracts (15-20 μg
of protein) were run in 10% sodium dodecyl sulfate
PAGE (PAGE; SDS-PAGE) gels and then wet-blotted to
nitrocellulose membranes (Amersham, Pittsburgh, PA,
USA). The whole cell extracts were prepared in MPERH
(Mammalian Protein Extraction Reagent, Thermo
Scientific,78501) according to the manufacturer’s
protocol. The membranes were blocked for 1 h in 3%
fat-free dry milk in 0.3% Tween-20/phosphate buffered
saline at room temperature (RT). Thereafter, the
membranes were incubated for 1 h at RT with rabbit
polyclonal ubiquitin antibody (cat. no. Z0458;
DakoCytomation, Glostrup, Denmark), mouse
monoclonal SQSTM1 (p62) antibody (cat. no. sc-28359;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), or
mouse monoclonal Hsp70 antibody (StressGen, Ann
Arbor, MI, USA). Primary antibodies were diluted
(1:500, 1:2000, or 1:5000, respectively) in 0.5% BSA
(BSA) in 0.3% Tween-20/PBS. After washing 3X for 10
min with 0.3% Tween-20/PBS, the membranes were
incubated for 1 h at RT with horseradish peroxidase-
conjugated antirabbit IgG or antimouse IgG antibodies
(GE Healthcare, Little Chalfont, Buckinghamshire, UK).
The secondary antibodies were diluted for ubiquitin
1:15000, for p62 1:25000, and for Hsp70 1:20000 in 3%
fat-free dry milk in 0.3% Tween-20/PBS. Before
detection, all of the membranes were washed as before.
Protein-antibody-complexes were detected with an
enhanced chemiluminescent assay for horseradish
peroxidise (Millipore, Billerica, MA, USA).
Experiments were performed in duplicate for each
different cell preparation and α-tubulin was used to
normalize the data. Statistical analysis of western blot
data was performed on the densitometric values obtained
with the NIH image software 1.61 (downloadable at
http://rsb.info.nih.gov/nih-image) and Quantity One®
software. 
Transmission electron microscopy
For transmission electron microscopy, the cells were
treated with different concentrations of MG-132 for 24
h. Cell culture samples were prefixed with 2.5%
glutaraldehyde in 0.1 M phosphate buffer pH 7.4 for 2 h
at RT. After 15 min washing in 0.1 M phosphate buffer,
the samples were post-fixed in 1% osmium tetraoxide
and 0.1 M phosphate buffer for 1 hour, and again washed
with phosphate buffer for 15 min prior to standard
ethanol dehydration. Subsequently, the samples were
infiltrated and embedded in LX-112 resin.
Polymerization was carried out at 37°C for 24 h and at
60°C for 48 h. The sections were examined with a JEM-
2100F transmission electron microscope (Jeol) at 200
kV). Aggregates were manually counted. Eight cells
were randomly selected from each group.
Results
Figure 1 shows the classical histological and clinical
appearance of macular corneal dystrophy. Histological
demonstration of Alcian blue staining indicates deposits
within individual keratocytes and between the collagen
fibers of the substantia propria in MCD buttons. In slit-
lamp examination stromal opacities with indistinct
borders and intervening haze can be observed. In vivo
corneal confocal microscopy analysis reveals
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abnormality in basal epithelial cell size and shape (Fig.
2). Cells become bigger and polygonal with bright
contours and they show intracellular aggregates. In the
anterior stroma hyperreflective keratocytes with
vacuoles were observed (Fig. 3). We found that Hsp70,
Ub and SQSTM1/p62, markers for impaired proteasomal
clearance, are highly expressed in the basal epithelium
of MCD samples (Fig. 4). A very weak Hsp70
immunostaining was mainly associated with the basal
cells of corneal epithelium in contrast to macular
dystrophy, where intense Hsp70 signals were recorded
throughout the cytoplasm of basal corneal epithelial cells
(Fig. 4A,B). In healthy controls Ub was only detected
around some cell nuclei of basal cells (Fig. 4C). In MCD
corneal buttons strong ubiquitin signals were obtained
from corneal epithelial cells (Fig. 4D). In healthy
corneas no SQSTM1/p62 immunoreactivity was
observed (Fig. 4E), whereas faintly elevated
924
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Fig. 1. Histological and clinical examination of cornea. Alcian blue staining for (A) normal human cornea and (B) MCD. Stromal deposits can be seen in
slit-lamp examination (C, D). Arrowheads stand for stromal deposits. Scale bar: 10 µm.
SQSTM1/p62 immunolabeling was present in corneal
epithelial cells in MCD (Fig. 4F). Fig. 4G and H
represent low magnification merged microphotos for
Hsp70, Ub and SQSTM1/p62 immunofluorescent
reaction of corneal epithelium from healthy (Fig. 4G)
and MCD corneal buttons (Fig. 4H), respectively. The
frames represent the areas shown in higher
magnification in panels (Fig. 4G1,H1). On Fig. 4H1
around the yellow (artificial color chosen for DAPI)
nucleus pink dots may indicate the colocalization of
Hsp70, Ub and SQSTM1/p62. 
The very low autofluorescent signal on Figure 5F
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Fig. 2. Confocal microscopy analysis from epithelium (300x300 μm, depth ~20 μm). A. Healthy control is shown in the left upper panel. B. In initial
dystrophy state abnormality in cell size and shape can be observed. Cells become bigger and polygonal with bright contours (1). Single cells show
intracellular deposits with saved cellular shape (2). C. In moderate MCD state still visible bright contoured, polygonal cells (3) with increased number of
deposits accumulate cells (4), shape of cells is still saved and no leaking out is observed. D. In severe MCD state there are single bright contoured cells
visible (5), as well as cells with deposits and saved shape (6) but the intensity of changes is higher.
indicating the present of intact Bowman membrane
(BM) of the healthy cornea button (dash line) compared
to the MCD samples, where due to the absent of BM
there was no signal observed (Fig. 5A). Note that the
stromal cells from MCD corneal buttons showed weak
Hsp70 positivity (Fig 5B, green), in association with
moderate Ub (Fig. 5C, red) and SQSTM1/p62 (Fig. 5D,
blue) immunolabelling. On the merged panel of Figure
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Fig. 3. Confocal microscopy analysis from anterior stroma (300x300 μm, depth ~150 μm). A. anterior stroma of healthy cornea with regular, condensed
keratocytes, small fibrilles, no vacuoles, dark background from high transparency stromal matrix. B and C. Hyperreflective keratocytes with presence of
vacuoles (1) - proof of accumulative activity in MCD, bright, homogenous background from stromal matrix cause blurring in MCD (2).
Fig. 4. High magnification microphotos of single laser scanning confocal optical sections of corneal basal epithelial cells layer (1 μm). Control samples
(upper panel) and MCD samples (lower panel) demonstrate the immunostaining of the anti-Hsp70 (A, B, green) and anti-ubiquitin-2 (C, D, red) and
anti-SQSTM1/p62 (E, F, blue) antibodies in corneal basal epithelial cells. G and H represent low magnification merged microphotos for Hsp70, Ub
protein conjugates and SQSTM1/p62 immunofluorescent reaction of corneal epithelium from healthy (G) and MCD corneal buttons (H). The frames
represent the areas (18x18 µm) shown in higher magnification in panels (G1), (H1). Triple immunofluorescence labeling of Hsp70, Ub protein
conjugates, and SQSTM1/p62 combined with DAPI (yellow) illustrates definitive labeling for these molecules in MCD cases. Note that no nuclear
staining is present on the merged images of G1 and H1 preclude the possibility of nonspecific reaction (internal control). On H1 around the yellow
(artificial color choosen for DAPI) nucleus pink dots may indicate the colocalization of these antibodies used. A-F, x 600; Scale bar: 10 µm.
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5E the colocalization of these proteins on the
“pseudopod-like” processes of stomal cells extending
parallel to the basal epithelial cells can be observed. 
Since in vivo data suggested impaired proteasomal
clearance at both basal corneal epithelium and stromal
keratocytes, we wanted to examine the effect of a
proteasome inhibitor in human HCE-2 corneal epithelial
cells in vitro. As shown in Figure 6, Hsp70, Ub
conjugates and SQSTM1/p62 protein levels strongly
increased in a concentration gradient dependent way in
response to MG-132 proteasome inhibitor in HCE-2
cells. This protein upregulation was accompanied by
perinuclear protein aggregation, when cells were
exposed to MG-132 proteasome inhibition and analyzed
by a transmission electron microscope (Fig.7). 
Discussion
Protein misfolding may promote cellular
degeneration and cell death (Kopito, 2000; Estey et al.,
2010; Underhaug et al., 2013, Viiri et al., 2013). All cells
have special surveillance systems to control steady-state
of the folding and clearance of proteins. Hsps are the
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Fig. 6. Proteasome inhibition upregulates Hsp70, ubiquitin protein
conjugates and SQSTM1/p62 in HCE-2 cells. Western blotting analysis
for evaluating the effects of different concentrations of protesome
inhibition (MG-132). Exposure for 24 hours on expression of Hsp70, Ub
protein conjugates and SQSTM1/p62. α-tubulin staining was used to
ensure equal loading of proteins.
Fg. 7. Proteasome inhibition increases perinuclear aggregates. A.
Transmission electron microscopy of control HCE-2 cells and from cells
exposed to 1 µM MG-132 for 24 hours. B. Quantification of aggregates per
cell. Eight parallel samples were measured in all treatments.
only system in cells to repair misfolding proteins and
release them as a functional unit (Hartl and Hayer-Hartl,
2009). They assist in the refolding of damaged proteins,
facilitate their translocation to their correct intracellular
localization and attempt to prevent aggregation of
proteins (Arrigo and Simon, 2010). If Hsps capacity to
refold proteins is exceeded damaged proteins are
targeted to UPP clearance machine (Jung et al., 2009).
UPP is the master proteolytic system in the cells that
clean misfolded Ub-labelled soluble proteins. Moreover,
lysosomal autophagy is integrated with proteasomal
degradation system (Ryhänen et al., 2009; Viiri et al.,
2013). In this study, we show that Hsp70 is accumulated
in both basal epithelium and stromal cells. A previous
immunohistochemical study indicates increased
apoptosis of epithelial cells, keratocytes and endothelial
cells in MCD (Szentmáry et al., 2007). Hsp70 has a
strong anti-apoptotic capacity (Beere et al., 2000; Saleh
et al., 2000; Ravagnan et al., 2001). Thus, upregulation
of Hsp70 reveals an attempt to repair misfolded proteins
and prevent cell death in MCD. 
The SQSTM1/p62 was first characterized in
polyubiquitinated protein aggregates in response to
proteasomal depletion (Kuusisto et al., 2001). The
ubiquitin-associated domain (UBA) of SQSTM1/p62
enables a non-covalent binding to ubiquitin or
ubiquitinated substrate proteins that are then targeted to
proteasomal degradation, where the N-terminal PB1
domain of p62 binds to the proteasome (Seibenhener et
al., 2004; Babu et al., 2005). Alternatively, ubiquitinated
complexes are shuttled to autophagocytic degradation
(Ryhänen et al., 2009; Viiri et al., 2013; Komatsu et al.,
2007; Pankiv et al., 2007; Kaarniranta et al., 2013).
Decreased proteasomal activity evokes Hsp70, Ub
protein conjugates and SQSTM1/p62 accumulation in
cells (Ryhänen et al., 2009; Viiri et al., 2010). We
observed a strong upregulation of Ub protein conjugates
and SQSTM1/p62 in both the basal epithelial cells and
the stromal keratocytes in MCD samples. This discovery
was supported by the western blot and TEM analysis
under proteasome inhibition in HCE-2 cells in vitro.
Although Hsp70, Ub protein conjugates and
SQSTM1/p62 localize to the same protein aggregation
area, it seems that Hsp70 differs in its function in
proteolysis. It is highly probable that the Hsp70
participates for protein folding processes, while Ub and
SQSTM1/p62 regulate clearance systems (Viiri et al.,
2010). Accumulated Ub protein conjugates and
SQSTM1 may also be a reflection of impaired
autophagy (Choi et al., 2012). Our recent observation
reveals that Hsp70 does not undergo autophagy
clearance (Kivinen et al., 2014). Since, Hsp70 is
upregulated in MCD samples it reveals at least partly
impaired proteasomal function in the pathology.
Understanding the intricate network of pathways that
maintain proteostasis and mediate stress response or
default into cell death is critical to understand MCD
pathology. We suggest a novel mechanism for the
pathogenesis of MCD that involves impaired
proteasomal clearance in both the corneal basal
epithelium and the stromal cells. Impaired cellular
proteolysis may also coincide with an increased
unfolding protein stress response in the endoplasmic
reticulum that disturbs protein processing and leads
finally to different deposit accumulations (Digaleh et al.,
2013), as it occurs in MCD.
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